The increase in the price target by a reputable analyst such as Anupam Rama from JP Morgan is a strong positive signal for Sage Therapeutics. It suggests a bullish outlook on the company's future performance and potential growth, likely leading to increased investor confidence and a potential rise in the stock price in the short term.